aluates Reports

$ 0.0

Automative

Global HER2-Positive Breast Cancer Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-15E6024

Global HER2 Positive Breast Cancer Market Insights and Forecast to 2028

BUY CHAPTERS

Global HER2-Positive Breast Cancer Market Research Report 2025

Code: QYRE-Auto-15E6024

Report

September 2025

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer (Pharmacia and Upjohn Company)

Novartis

AstraZeneca Pharmaceuticals

Eli Lilly

Roche Group

Merck

Jiangsu Hengrui Medicine

Odonate Therapeutics

Radius Pharmaceuticals

Immunomedics

Syndax Pharmaceuticals

Bayer

Eagle Pharmaceuticals

Merrimack Pharmaceuticals

GlaxoSmithKline PLC

Millennium Pharmaceuticals

HER2-Positive Breast Cancer Market

The global market for HER2-Positive Breast Cancer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

HER2, also known as human epidermal growth factor receptor 2, is an important prognostic factor for breast cancer.HER2 is also expressed on the surface of some normal cells in the body.Her2-positive breast cancer is characterized by strong invasion, more recurrence and metastasis, and short disease-free survival.

North American market for HER2-Positive Breast Cancer is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for HER2-Positive Breast Cancer is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for HER2-Positive Breast Cancer in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of HER2-Positive Breast Cancer include Pfizer (Pharmacia and Upjohn Company), Novartis, AstraZeneca Pharmaceuticals, Eli Lilly, Roche Group, Merck, Jiangsu HengRui Medicine, Odonate Therapeutics, Radius Pharmaceuticals, Immunomedics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for HER2-Positive Breast Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HER2-Positive Breast Cancer.

The HER2-Positive Breast Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HER2-Positive Breast Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the HER2-Positive Breast Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of HER2-Positive Breast Cancer Market Report

Report Metric	Details
Report Name	HER2-Positive Breast Cancer Market
Segment by Type	Grifola Frondosa Surgery Radiation and Chemotherapy Endocrine Therapy Molecular Targeted Therapy
Segment by Application	Hospital Specialist Clinic Biotechnology and Pharmaceutical Companies Research and Academic Institutions Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer (Pharmacia and Upjohn Company), Novartis, AstraZeneca Pharmaceuticals, Eli Lilly, Roche Group, Merck, Jiangsu HengRui Medicine, Odonate Therapeutics, Radius Pharmaceuticals, Immunomedics, Syndax Pharmaceuticals, Bayer, Eagle Pharmaceuticals, Merrimack Pharmaceuticals, GlaxoSmithKline, Millennium Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HER2-Positive Breast Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the HER2-Positive Breast Cancer Market report?

Ans: The main players in the HER2-Positive Breast Cancer Market are Pfizer (Pharmacia and Upjohn Company), Novartis, AstraZeneca Pharmaceuticals, Eli Lilly, Roche Group, Merck, Jiangsu HengRui Medicine, Odonate Therapeutics, Radius Pharmaceuticals, Immunomedics, Syndax Pharmaceuticals, Bayer, Eagle Pharmaceuticals, Merrimack Pharmaceuticals, GlaxoSmithKline, Millennium Pharmaceuticals

What are the Application segmentation covered in the HER2-Positive Breast Cancer Market report?

Ans: The Applications covered in the HER2-Positive Breast Cancer Market report are Hospital, Specialist Clinic, Biotechnology and Pharmaceutical Companies, Research and Academic Institutions, Other

What are the Type segmentation covered in the HER2-Positive Breast Cancer Market report?

Ans: The Types covered in the HER2-Positive Breast Cancer Market report are Grifola Frondosa, Surgery, Radiation and Chemotherapy, Endocrine Therapy, Molecular Targeted Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global HER2-Positive Breast Cancer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Grifola Frondosa

1.2.3 Surgery

1.2.4 Radiation and Chemotherapy

1.2.5 Endocrine Therapy

1.2.6 Molecular Targeted Therapy

1.3 Market by Application

1.3.1 Global HER2-Positive Breast Cancer Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Specialist Clinic

1.3.4 Biotechnology and Pharmaceutical Companies

1.3.5 Research and Academic Institutions

1.3.6 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global HER2-Positive Breast Cancer Market Perspective (2020-2031)

2.2 Global HER2-Positive Breast Cancer Growth Trends by Region

2.2.1 Global HER2-Positive Breast Cancer Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 HER2-Positive Breast Cancer Historic Market Size by Region (2020-2025)

2.2.3 HER2-Positive Breast Cancer Forecasted Market Size by Region (2026-2031)

2.3 HER2-Positive Breast Cancer Market Dynamics

2.3.1 HER2-Positive Breast Cancer Industry Trends

2.3.2 HER2-Positive Breast Cancer Market Drivers

2.3.3 HER2-Positive Breast Cancer Market Challenges

2.3.4 HER2-Positive Breast Cancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top HER2-Positive Breast Cancer Players by Revenue

3.1.1 Global Top HER2-Positive Breast Cancer Players by Revenue (2020-2025)

3.1.2 Global HER2-Positive Breast Cancer Revenue Market Share by Players (2020-2025)

3.2 Global HER2-Positive Breast Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by HER2-Positive Breast Cancer Revenue

3.4 Global HER2-Positive Breast Cancer Market Concentration Ratio

3.4.1 Global HER2-Positive Breast Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by HER2-Positive Breast Cancer Revenue in 2024

3.5 Global Key Players of HER2-Positive Breast Cancer Head office and Area Served

3.6 Global Key Players of HER2-Positive Breast Cancer, Product and Application

3.7 Global Key Players of HER2-Positive Breast Cancer, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 HER2-Positive Breast Cancer Breakdown Data by Type

4.1 Global HER2-Positive Breast Cancer Historic Market Size by Type (2020-2025)

4.2 Global HER2-Positive Breast Cancer Forecasted Market Size by Type (2026-2031)

5 HER2-Positive Breast Cancer Breakdown Data by Application

5.1 Global HER2-Positive Breast Cancer Historic Market Size by Application (2020-2025)

5.2 Global HER2-Positive Breast Cancer Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America HER2-Positive Breast Cancer Market Size (2020-2031)

6.2 North America HER2-Positive Breast Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America HER2-Positive Breast Cancer Market Size by Country (2020-2025)

6.4 North America HER2-Positive Breast Cancer Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe HER2-Positive Breast Cancer Market Size (2020-2031)

7.2 Europe HER2-Positive Breast Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe HER2-Positive Breast Cancer Market Size by Country (2020-2025)

7.4 Europe HER2-Positive Breast Cancer Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific HER2-Positive Breast Cancer Market Size (2020-2031)

8.2 Asia-Pacific HER2-Positive Breast Cancer Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific HER2-Positive Breast Cancer Market Size by Region (2020-2025)

8.4 Asia-Pacific HER2-Positive Breast Cancer Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America HER2-Positive Breast Cancer Market Size (2020-2031)

9.2 Latin America HER2-Positive Breast Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America HER2-Positive Breast Cancer Market Size by Country (2020-2025)

9.4 Latin America HER2-Positive Breast Cancer Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa HER2-Positive Breast Cancer Market Size (2020-2031)

10.2 Middle East & Africa HER2-Positive Breast Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa HER2-Positive Breast Cancer Market Size by Country (2020-2025)

10.4 Middle East & Africa HER2-Positive Breast Cancer Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer (Pharmacia and Upjohn Company)

11.1.1 Pfizer (Pharmacia and Upjohn Company) Company Details

11.1.2 Pfizer (Pharmacia and Upjohn Company) Business Overview

11.1.3 Pfizer (Pharmacia and Upjohn Company) HER2-Positive Breast Cancer Introduction

11.1.4 Pfizer (Pharmacia and Upjohn Company) Revenue in HER2-Positive Breast Cancer Business (2020-2025)

11.1.5 Pfizer (Pharmacia and Upjohn Company) Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis HER2-Positive Breast Cancer Introduction

11.2.4 Novartis Revenue in HER2-Positive Breast Cancer Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 AstraZeneca Pharmaceuticals

11.3.1 AstraZeneca Pharmaceuticals Company Details

11.3.2 AstraZeneca Pharmaceuticals Business Overview

11.3.3 AstraZeneca Pharmaceuticals HER2-Positive Breast Cancer Introduction

11.3.4 AstraZeneca Pharmaceuticals Revenue in HER2-Positive Breast Cancer Business (2020-2025)

11.3.5 AstraZeneca Pharmaceuticals Recent Development

11.4 Eli Lilly

11.4.1 Eli Lilly Company Details

11.4.2 Eli Lilly Business Overview

11.4.3 Eli Lilly HER2-Positive Breast Cancer Introduction

11.4.4 Eli Lilly Revenue in HER2-Positive Breast Cancer Business (2020-2025)

11.4.5 Eli Lilly Recent Development

11.5 Roche Group

11.5.1 Roche Group Company Details

11.5.2 Roche Group Business Overview

11.5.3 Roche Group HER2-Positive Breast Cancer Introduction

11.5.4 Roche Group Revenue in HER2-Positive Breast Cancer Business (2020-2025)

11.5.5 Roche Group Recent Development

11.6 Merck

11.6.1 Merck Company Details

11.6.2 Merck Business Overview

11.6.3 Merck HER2-Positive Breast Cancer Introduction

11.6.4 Merck Revenue in HER2-Positive Breast Cancer Business (2020-2025)

11.6.5 Merck Recent Development

11.7 Jiangsu HengRui Medicine

11.7.1 Jiangsu HengRui Medicine Company Details

11.7.2 Jiangsu HengRui Medicine Business Overview

11.7.3 Jiangsu HengRui Medicine HER2-Positive Breast Cancer Introduction

11.7.4 Jiangsu HengRui Medicine Revenue in HER2-Positive Breast Cancer Business (2020-2025)

11.7.5 Jiangsu HengRui Medicine Recent Development

11.8 Odonate Therapeutics

11.8.1 Odonate Therapeutics Company Details

11.8.2 Odonate Therapeutics Business Overview

11.8.3 Odonate Therapeutics HER2-Positive Breast Cancer Introduction

11.8.4 Odonate Therapeutics Revenue in HER2-Positive Breast Cancer Business (2020-2025)

11.8.5 Odonate Therapeutics Recent Development

11.9 Radius Pharmaceuticals

11.9.1 Radius Pharmaceuticals Company Details

11.9.2 Radius Pharmaceuticals Business Overview

11.9.3 Radius Pharmaceuticals HER2-Positive Breast Cancer Introduction

11.9.4 Radius Pharmaceuticals Revenue in HER2-Positive Breast Cancer Business (2020-2025)

11.9.5 Radius Pharmaceuticals Recent Development

11.10 Immunomedics

11.10.1 Immunomedics Company Details

11.10.2 Immunomedics Business Overview

11.10.3 Immunomedics HER2-Positive Breast Cancer Introduction

11.10.4 Immunomedics Revenue in HER2-Positive Breast Cancer Business (2020-2025)

11.10.5 Immunomedics Recent Development

11.11 Syndax Pharmaceuticals

11.11.1 Syndax Pharmaceuticals Company Details

11.11.2 Syndax Pharmaceuticals Business Overview

11.11.3 Syndax Pharmaceuticals HER2-Positive Breast Cancer Introduction

11.11.4 Syndax Pharmaceuticals Revenue in HER2-Positive Breast Cancer Business (2020-2025)

11.11.5 Syndax Pharmaceuticals Recent Development

11.12 Bayer

11.12.1 Bayer Company Details

11.12.2 Bayer Business Overview

11.12.3 Bayer HER2-Positive Breast Cancer Introduction

11.12.4 Bayer Revenue in HER2-Positive Breast Cancer Business (2020-2025)

11.12.5 Bayer Recent Development

11.13 Eagle Pharmaceuticals

11.13.1 Eagle Pharmaceuticals Company Details

11.13.2 Eagle Pharmaceuticals Business Overview

11.13.3 Eagle Pharmaceuticals HER2-Positive Breast Cancer Introduction

11.13.4 Eagle Pharmaceuticals Revenue in HER2-Positive Breast Cancer Business (2020-2025)

11.13.5 Eagle Pharmaceuticals Recent Development

11.14 Merrimack Pharmaceuticals

11.14.1 Merrimack Pharmaceuticals Company Details

11.14.2 Merrimack Pharmaceuticals Business Overview

11.14.3 Merrimack Pharmaceuticals HER2-Positive Breast Cancer Introduction

11.14.4 Merrimack Pharmaceuticals Revenue in HER2-Positive Breast Cancer Business (2020-2025)

11.14.5 Merrimack Pharmaceuticals Recent Development

11.15 GlaxoSmithKline

11.15.1 GlaxoSmithKline Company Details

11.15.2 GlaxoSmithKline Business Overview

11.15.3 GlaxoSmithKline HER2-Positive Breast Cancer Introduction

11.15.4 GlaxoSmithKline Revenue in HER2-Positive Breast Cancer Business (2020-2025)

11.15.5 GlaxoSmithKline Recent Development

11.16 Millennium Pharmaceuticals

11.16.1 Millennium Pharmaceuticals Company Details

11.16.2 Millennium Pharmaceuticals Business Overview

11.16.3 Millennium Pharmaceuticals HER2-Positive Breast Cancer Introduction

11.16.4 Millennium Pharmaceuticals Revenue in HER2-Positive Breast Cancer Business (2020-2025)

11.16.5 Millennium Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer (Pharmacia and Upjohn Company)

Novartis

AstraZeneca Pharmaceuticals

Eli Lilly

Roche Group

Merck

Jiangsu Hengrui Medicine

Odonate Therapeutics

Radius Pharmaceuticals

Immunomedics

Syndax Pharmaceuticals

Bayer

Eagle Pharmaceuticals

Merrimack Pharmaceuticals

GlaxoSmithKline PLC

Millennium Pharmaceuticals

List of Tables

Table 1. Global HER2-Positive Breast Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Grifola Frondosa

Table 3. Key Players of Surgery

Table 4. Key Players of Radiation and Chemotherapy

Table 5. Key Players of Endocrine Therapy

Table 6. Key Players of Molecular Targeted Therapy

Table 7. Global HER2-Positive Breast Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global HER2-Positive Breast Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global HER2-Positive Breast Cancer Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global HER2-Positive Breast Cancer Market Share by Region (2020-2025)

Table 11. Global HER2-Positive Breast Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global HER2-Positive Breast Cancer Market Share by Region (2026-2031)

Table 13. HER2-Positive Breast Cancer Market Trends

Table 14. HER2-Positive Breast Cancer Market Drivers

Table 15. HER2-Positive Breast Cancer Market Challenges

Table 16. HER2-Positive Breast Cancer Market Restraints

Table 17. Global HER2-Positive Breast Cancer Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global HER2-Positive Breast Cancer Market Share by Players (2020-2025)

Table 19. Global Top HER2-Positive Breast Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2-Positive Breast Cancer as of 2024)

Table 20. Ranking of Global Top HER2-Positive Breast Cancer Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by HER2-Positive Breast Cancer Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of HER2-Positive Breast Cancer, Headquarters and Area Served

Table 23. Global Key Players of HER2-Positive Breast Cancer, Product and Application

Table 24. Global Key Players of HER2-Positive Breast Cancer, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global HER2-Positive Breast Cancer Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global HER2-Positive Breast Cancer Revenue Market Share by Type (2020-2025)

Table 28. Global HER2-Positive Breast Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global HER2-Positive Breast Cancer Revenue Market Share by Type (2026-2031)

Table 30. Global HER2-Positive Breast Cancer Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global HER2-Positive Breast Cancer Revenue Market Share by Application (2020-2025)

Table 32. Global HER2-Positive Breast Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global HER2-Positive Breast Cancer Revenue Market Share by Application (2026-2031)

Table 34. North America HER2-Positive Breast Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America HER2-Positive Breast Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America HER2-Positive Breast Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe HER2-Positive Breast Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe HER2-Positive Breast Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe HER2-Positive Breast Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific HER2-Positive Breast Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific HER2-Positive Breast Cancer Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific HER2-Positive Breast Cancer Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America HER2-Positive Breast Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America HER2-Positive Breast Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America HER2-Positive Breast Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa HER2-Positive Breast Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa HER2-Positive Breast Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa HER2-Positive Breast Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 49. Pfizer (Pharmacia and Upjohn Company) Company Details

Table 50. Pfizer (Pharmacia and Upjohn Company) Business Overview

Table 51. Pfizer (Pharmacia and Upjohn Company) HER2-Positive Breast Cancer Product

Table 52. Pfizer (Pharmacia and Upjohn Company) Revenue in HER2-Positive Breast Cancer Business (2020-2025) & (US$ Million)

Table 53. Pfizer (Pharmacia and Upjohn Company) Recent Development

Table 54. Novartis Company Details

Table 55. Novartis Business Overview

Table 56. Novartis HER2-Positive Breast Cancer Product

Table 57. Novartis Revenue in HER2-Positive Breast Cancer Business (2020-2025) & (US$ Million)

Table 58. Novartis Recent Development

Table 59. AstraZeneca Pharmaceuticals Company Details

Table 60. AstraZeneca Pharmaceuticals Business Overview

Table 61. AstraZeneca Pharmaceuticals HER2-Positive Breast Cancer Product

Table 62. AstraZeneca Pharmaceuticals Revenue in HER2-Positive Breast Cancer Business (2020-2025) & (US$ Million)

Table 63. AstraZeneca Pharmaceuticals Recent Development

Table 64. Eli Lilly Company Details

Table 65. Eli Lilly Business Overview

Table 66. Eli Lilly HER2-Positive Breast Cancer Product

Table 67. Eli Lilly Revenue in HER2-Positive Breast Cancer Business (2020-2025) & (US$ Million)

Table 68. Eli Lilly Recent Development

Table 69. Roche Group Company Details

Table 70. Roche Group Business Overview

Table 71. Roche Group HER2-Positive Breast Cancer Product

Table 72. Roche Group Revenue in HER2-Positive Breast Cancer Business (2020-2025) & (US$ Million)

Table 73. Roche Group Recent Development

Table 74. Merck Company Details

Table 75. Merck Business Overview

Table 76. Merck HER2-Positive Breast Cancer Product

Table 77. Merck Revenue in HER2-Positive Breast Cancer Business (2020-2025) & (US$ Million)

Table 78. Merck Recent Development

Table 79. Jiangsu HengRui Medicine Company Details

Table 80. Jiangsu HengRui Medicine Business Overview

Table 81. Jiangsu HengRui Medicine HER2-Positive Breast Cancer Product

Table 82. Jiangsu HengRui Medicine Revenue in HER2-Positive Breast Cancer Business (2020-2025) & (US$ Million)

Table 83. Jiangsu HengRui Medicine Recent Development

Table 84. Odonate Therapeutics Company Details

Table 85. Odonate Therapeutics Business Overview

Table 86. Odonate Therapeutics HER2-Positive Breast Cancer Product

Table 87. Odonate Therapeutics Revenue in HER2-Positive Breast Cancer Business (2020-2025) & (US$ Million)

Table 88. Odonate Therapeutics Recent Development

Table 89. Radius Pharmaceuticals Company Details

Table 90. Radius Pharmaceuticals Business Overview

Table 91. Radius Pharmaceuticals HER2-Positive Breast Cancer Product

Table 92. Radius Pharmaceuticals Revenue in HER2-Positive Breast Cancer Business (2020-2025) & (US$ Million)

Table 93. Radius Pharmaceuticals Recent Development

Table 94. Immunomedics Company Details

Table 95. Immunomedics Business Overview

Table 96. Immunomedics HER2-Positive Breast Cancer Product

Table 97. Immunomedics Revenue in HER2-Positive Breast Cancer Business (2020-2025) & (US$ Million)

Table 98. Immunomedics Recent Development

Table 99. Syndax Pharmaceuticals Company Details

Table 100. Syndax Pharmaceuticals Business Overview

Table 101. Syndax Pharmaceuticals HER2-Positive Breast Cancer Product

Table 102. Syndax Pharmaceuticals Revenue in HER2-Positive Breast Cancer Business (2020-2025) & (US$ Million)

Table 103. Syndax Pharmaceuticals Recent Development

Table 104. Bayer Company Details

Table 105. Bayer Business Overview

Table 106. Bayer HER2-Positive Breast Cancer Product

Table 107. Bayer Revenue in HER2-Positive Breast Cancer Business (2020-2025) & (US$ Million)

Table 108. Bayer Recent Development

Table 109. Eagle Pharmaceuticals Company Details

Table 110. Eagle Pharmaceuticals Business Overview

Table 111. Eagle Pharmaceuticals HER2-Positive Breast Cancer Product

Table 112. Eagle Pharmaceuticals Revenue in HER2-Positive Breast Cancer Business (2020-2025) & (US$ Million)

Table 113. Eagle Pharmaceuticals Recent Development

Table 114. Merrimack Pharmaceuticals Company Details

Table 115. Merrimack Pharmaceuticals Business Overview

Table 116. Merrimack Pharmaceuticals HER2-Positive Breast Cancer Product

Table 117. Merrimack Pharmaceuticals Revenue in HER2-Positive Breast Cancer Business (2020-2025) & (US$ Million)

Table 118. Merrimack Pharmaceuticals Recent Development

Table 119. GlaxoSmithKline Company Details

Table 120. GlaxoSmithKline Business Overview

Table 121. GlaxoSmithKline HER2-Positive Breast Cancer Product

Table 122. GlaxoSmithKline Revenue in HER2-Positive Breast Cancer Business (2020-2025) & (US$ Million)

Table 123. GlaxoSmithKline Recent Development

Table 124. Millennium Pharmaceuticals Company Details

Table 125. Millennium Pharmaceuticals Business Overview

Table 126. Millennium Pharmaceuticals HER2-Positive Breast Cancer Product

Table 127. Millennium Pharmaceuticals Revenue in HER2-Positive Breast Cancer Business (2020-2025) & (US$ Million)

Table 128. Millennium Pharmaceuticals Recent Development

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

Table 132. Authors List of This Report

List of Figures

Figure 1. HER2-Positive Breast Cancer Picture

Figure 2. Global HER2-Positive Breast Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global HER2-Positive Breast Cancer Market Share by Type: 2024 VS 2031

Figure 4. Grifola Frondosa Features

Figure 5. Surgery Features

Figure 6. Radiation and Chemotherapy Features

Figure 7. Endocrine Therapy Features

Figure 8. Molecular Targeted Therapy Features

Figure 9. Global HER2-Positive Breast Cancer Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global HER2-Positive Breast Cancer Market Share by Application: 2024 VS 2031

Figure 11. Hospital Case Studies

Figure 12. Specialist Clinic Case Studies

Figure 13. Biotechnology and Pharmaceutical Companies Case Studies

Figure 14. Research and Academic Institutions Case Studies

Figure 15. Other Case Studies

Figure 16. HER2-Positive Breast Cancer Report Years Considered

Figure 17. Global HER2-Positive Breast Cancer Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global HER2-Positive Breast Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global HER2-Positive Breast Cancer Market Share by Region: 2024 VS 2031

Figure 20. Global HER2-Positive Breast Cancer Market Share by Players in 2024

Figure 21. Global Top HER2-Positive Breast Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2-Positive Breast Cancer as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by HER2-Positive Breast Cancer Revenue in 2024

Figure 23. North America HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America HER2-Positive Breast Cancer Market Share by Country (2020-2031)

Figure 25. United States HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe HER2-Positive Breast Cancer Market Share by Country (2020-2031)

Figure 29. Germany HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific HER2-Positive Breast Cancer Market Share by Region (2020-2031)

Figure 37. China HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America HER2-Positive Breast Cancer Market Share by Country (2020-2031)

Figure 45. Mexico HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa HER2-Positive Breast Cancer Market Share by Country (2020-2031)

Figure 49. Turkey HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE HER2-Positive Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Pfizer (Pharmacia and Upjohn Company) Revenue Growth Rate in HER2-Positive Breast Cancer Business (2020-2025)

Figure 53. Novartis Revenue Growth Rate in HER2-Positive Breast Cancer Business (2020-2025)

Figure 54. AstraZeneca Pharmaceuticals Revenue Growth Rate in HER2-Positive Breast Cancer Business (2020-2025)

Figure 55. Eli Lilly Revenue Growth Rate in HER2-Positive Breast Cancer Business (2020-2025)

Figure 56. Roche Group Revenue Growth Rate in HER2-Positive Breast Cancer Business (2020-2025)

Figure 57. Merck Revenue Growth Rate in HER2-Positive Breast Cancer Business (2020-2025)

Figure 58. Jiangsu HengRui Medicine Revenue Growth Rate in HER2-Positive Breast Cancer Business (2020-2025)

Figure 59. Odonate Therapeutics Revenue Growth Rate in HER2-Positive Breast Cancer Business (2020-2025)

Figure 60. Radius Pharmaceuticals Revenue Growth Rate in HER2-Positive Breast Cancer Business (2020-2025)

Figure 61. Immunomedics Revenue Growth Rate in HER2-Positive Breast Cancer Business (2020-2025)

Figure 62. Syndax Pharmaceuticals Revenue Growth Rate in HER2-Positive Breast Cancer Business (2020-2025)

Figure 63. Bayer Revenue Growth Rate in HER2-Positive Breast Cancer Business (2020-2025)

Figure 64. Eagle Pharmaceuticals Revenue Growth Rate in HER2-Positive Breast Cancer Business (2020-2025)

Figure 65. Merrimack Pharmaceuticals Revenue Growth Rate in HER2-Positive Breast Cancer Business (2020-2025)

Figure 66. GlaxoSmithKline Revenue Growth Rate in HER2-Positive Breast Cancer Business (2020-2025)

Figure 67. Millennium Pharmaceuticals Revenue Growth Rate in HER2-Positive Breast Cancer Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global HER2 Antibody Market Research Report 2025

Global HER2 Human Epidermal Growth Factor Receptor 2 Inhibitors Market Research Report 2024

Global HER2 Tumor Marker Testing Market Research Report 2024

Global Anti HER2 Therapy Market Research Report 2025

Global HR HER2 Breast Cancer Market Research Report 2024

Global Mono Antibody mAb for HER2 Positive Advanced Breast Cancer Market Research Report 2024

Global Epidermal Growth Factor Receptor EGFR Inhibitor Market Insights Forecast to 2030

Global HER2 Target Drugs Market Research Report 2024

Global Herceptin Trastuzumab Market Research Report 2024

Global HER2 Targeted Therapy Market Research Report 2024

Global HER2 ELISA Kits Market Research Report 2024

HER2 Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for HR HER2 Advanced Breast Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

HER 2 Negative Breast Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HER2 Inhibitors Market Research Report 2024

Global HER 2 Targeted Drugs for Breast Cancer Market Research Report 2024

Global Cosmetic Grade EGF Market Research Report 2025

Global Human EGFR Gene Mutation Detection Kit Market Research Report 2024

Global HER2 Antibody Drug Conjugate Market Research Report 2025

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4H16852

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37K16619

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30U16301

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2G16953

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions